The real residual risk in patients with cardiovascular disease and diabetes: the promise of epigenetics.
25 August 2018 (00:00 - 00:00)
Organised by:
About the speaker
AmsterdamUMC location AMC, Amsterdam (Netherlands (The))
4 More presentations in this session
Doctor J. Plutzky (Boston, US)
A clinical view on BET inhibition in targeting residual risk in cardiovascular disease and diabetes.
Professor K. Ray (London, GB)
Access the full session
The Event
ESC Congress 2018
25 August - 29 August 2018
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
